LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

Repurposing existing drugs, including antibiotics, antivirals, and vaccines, may offer a promising strategy for combating ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Broad classes of drugs, including antibiotics, antivirals, vaccines, anti-inflammatories and antihypertensives, were ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...